Oncodesign Precision Medicine S.A. (ALOPM) Stock Forecast & Price Target
ALOPM Analyst Ratings
There are no analyst ratings in the last 3 months.
ALOPM Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
No analyst ratings match these filters.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ALOPM Financial Forecast
ConsensusEUR -0.11
ALOPM Earnings Forecast
Next quarter’s earnings estimate for ALOPM is -EUR 0.11 with a range of ― to ―. The previous quarter’s EPS was -EUR 0.11. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
ConsensusEUR 110K
ALOPM Sales Forecast
Next quarter’s sales forecast for ALOPM is EUR 110.00K with a range of ― to ―. The previous quarter’s sales results were EUR 110.00K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
ALOPM Stock Forecast FAQ
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Oncodesign Precision Medicine S.A.?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Oncodesign Precision Medicine S.A.?
To buy shares of FR:ALOPM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
